← FDA Drug Approvals (Drugs@FDA)

TAVABOROLE

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: CIPLA · Approved 2021-02-09

Drug application

FDA Application #

ANDA212224

Application type

Abbreviated New Drug Application (Generic)

Brand name

TAVABOROLE

Generic name

TAVABOROLE

Active ingredients

TAVABOROLE

Dosage form

SOLUTION

Route

TOPICAL

Marketing status

Discontinued

Sponsor

CIPLA

Manufacturer

Cipla USA Inc.

First approval

2021-02-09

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown